INmune Bio, Inc. (INMB)
NASDAQ·Healthcare·Biotechnology
$1.41
-4.42%
Mkt Cap $39.08M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
Implied Upside
+1465.8%
Consensus $22.00 vs current $1.41
NASDAQ·Healthcare·Biotechnology
$1.41
-4.42%
Mkt Cap $39.08M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$22.00
Range $22.00 – $22.00
+1465.8%
Consensus $22.00 vs current $1.41